In this study, the effect of fluconazole prophylaxis on the incidence of fungal (yeast) colonization in multidisciplinary ICU patients were investigated. A total of 252 patients were mycologically screened in the first week of their hospitalization and followingly once every week. The specimens studied were blood (from venous route and from central venous catheter) urine catheter, endotracheal tubes, oral cavity, nares, skin and rectal swabs. The fungus isolated was candida. 91 received fluconazole 100 mg/day IV or enterally for prophylaxis and 161 served as the control group. Total number of samples in study was 2852 and 1723 of these samples were from the control group, 27.5% being positive. 1129 samples were taken from the prophylaxis gr...
Background: Invasive fungal infections (IFIs) remain one of the worrying complications in patients w...
Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care...
Abstract From March, 1990 to February, 1992, we administered fluconazole as antifungal prophylaxis ...
AbstractObjectiveInvasive fungal infections are common in critically ill patients specially those on...
Antifungal prophylaxis is regularly used during treatment of patients with some cancers, as subgroup...
To evaluate the prophylactic use of enteral fluconazole to pre-vent invasive candidal infections in ...
Objective: Invasive fungal infections are common in critically ill patients specially those on prolo...
OBJECTIVE: Infections caused by Candida spp. are a major cause of morbidity and mortality in critica...
OBJECTIVES: To evaluate the efficacy of low dose fluconazole treatment for the prevention of yeast c...
INTRODUCTION: High-risk surgical patients are at increased risk of fungal infections and candidaemia...
OBJECTIVE: To evaluate the efficacy and safety of intravenous fluconazole for the prevention of intr...
AbstractAlthough abdominal surgery is an established risk factor for invasive candidiasis, the preci...
International audienceTo assess the evolution of patient deep colonization by Candida spp. in a surg...
ABSTRACTInvasive fungal infections (IFIs) are now the main cause of death from infection in cases of...
Breakthrough candidemia (BTC) on fluconazole was associated with non-susceptible Candida spp. and in...
Background: Invasive fungal infections (IFIs) remain one of the worrying complications in patients w...
Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care...
Abstract From March, 1990 to February, 1992, we administered fluconazole as antifungal prophylaxis ...
AbstractObjectiveInvasive fungal infections are common in critically ill patients specially those on...
Antifungal prophylaxis is regularly used during treatment of patients with some cancers, as subgroup...
To evaluate the prophylactic use of enteral fluconazole to pre-vent invasive candidal infections in ...
Objective: Invasive fungal infections are common in critically ill patients specially those on prolo...
OBJECTIVE: Infections caused by Candida spp. are a major cause of morbidity and mortality in critica...
OBJECTIVES: To evaluate the efficacy of low dose fluconazole treatment for the prevention of yeast c...
INTRODUCTION: High-risk surgical patients are at increased risk of fungal infections and candidaemia...
OBJECTIVE: To evaluate the efficacy and safety of intravenous fluconazole for the prevention of intr...
AbstractAlthough abdominal surgery is an established risk factor for invasive candidiasis, the preci...
International audienceTo assess the evolution of patient deep colonization by Candida spp. in a surg...
ABSTRACTInvasive fungal infections (IFIs) are now the main cause of death from infection in cases of...
Breakthrough candidemia (BTC) on fluconazole was associated with non-susceptible Candida spp. and in...
Background: Invasive fungal infections (IFIs) remain one of the worrying complications in patients w...
Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care...
Abstract From March, 1990 to February, 1992, we administered fluconazole as antifungal prophylaxis ...